TCIM
USNA icon

TIAA CREF Investment Management’s Usana Health Sciences USNA Stock Holding History

TIAA CREF Investment Management’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$3.72M Sell
44,383
-160,912
-78% -$16.8M ﹤0.01% 1628
2018
Q4 		$24.2M Buy
205,295
+12,619
+7% +$1.46M 0.02% 584
2018
Q3 		$23.2M Buy
192,676
+432
+0.2% +$53.6K 0.02% 686
2018
Q2 		$22.2M Buy
192,244
+99,467
+107% +$10.9M 0.01% 694
2018
Q1 		$7.97M Buy
92,777
+19,962
+27% +$1.55M 0.01% 1266
2017
Q4 		$5.39M Sell
72,815
-11,191
-13% -$749K ﹤0.01% 1556
2017
Q3 		$4.85M Sell
84,006
-34,060
-29% -$2.01M ﹤0.01% 1647
2017
Q2 		$7.57M Buy
118,066
+26,152
+28% +$1.61M 0.01% 1310
2017
Q1 		$5.29M Sell
91,914
-2,478
-3% -$148K ﹤0.01% 1562
2016
Q4 		$5.78M Sell
94,392
-2,128
-2% -$139K ﹤0.01% 1503
2016
Q3 		$6.68K Buy
96,520
+9,494
+11% +$626K ﹤0.01% 1409
2016
Q2 		$4.85M Sell
87,026
-252
-0.3% -$15.2K ﹤0.01% 1554
2016
Q1 		$5.3M Sell
87,278
-744
-0.8% -$43.8K ﹤0.01% 1470
2015
Q4 		$5.62M Sell
88,022
-2,168
-2% -$141K ﹤0.01% 1486
2015
Q3 		$6.04M Buy
90,190
+50,028
+125% +$3.54M ﹤0.01% 1411
2015
Q2 		$2.74M Sell
40,162
-928
-2% -$58.9K ﹤0.01% 2098
2015
Q1 		$2.28M Sell
41,090
-3,450
-8% -$177K ﹤0.01% 2154
2014
Q4 		$2.29M Sell
44,540
-4,786
-10% -$235K ﹤0.01% 2146
2014
Q3 		$1.82M Sell
49,326
-854
-2% -$30.8K ﹤0.01% 2282
2014
Q2 		$1.96M Buy
50,180
+1,738
+4% +$64.5K ﹤0.01% 2312
2014
Q1 		$1.82M Sell
48,442
-1,260
-3% -$44K ﹤0.01% 2291
2013
Q4 		$1.88M Hold
49,702
– – ﹤0.01% 2297
2013
Q3 		$2.16M Sell
49,702
-508
-1% -$20.4K ﹤0.01% 2154
2013
Q2 		$1.82M Buy
+50,210
New +$1.53M ﹤0.01% 2225

Other funds holding USNA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
JIM
Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

TIAA CREF Investment Management's USNA Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Usana Health Sciences (USNA) stake by 78% in Q1 2019, selling an estimated $16.8M and leaving 44,383 shares worth $3.72M. The position accounts for ﹤0.01% of the portfolio, ranked #1628.

TIAA CREF Investment Management first reported a position in USNA in Q2 2013 and has held it in 24 quarters since. The position peaked at $24.2M in Q4 2018. 188 funds tracked by Wall St. Rank hold USNA as of Q1 2019.

  • TIAA CREF Investment Management held 44,383 shares of Usana Health Sciences worth $3.72M as of Q1 2019.
  • TIAA CREF Investment Management sold 160,912 Usana Health Sciences shares in Q1 2019, an estimated $16.8M.
  • Usana Health Sciences made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #1628 holding.
  • TIAA CREF Investment Management first reported a position in Usana Health Sciences in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's Usana Health Sciences position peaked at $24.2M in Q4 2018.
  • 188 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.